Search

everythinglearnresearchcommunity

for

Search:↓

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Modified superoxide dismutase may trigger an autoimmune response in alopecia areata.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Collecting hair for cortisol analysis is possible in low-income mother-toddler pairs.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.

Using existing drugs for new treatments is cost-effective and safer.

Women with PCOS often experience mental health issues like depression and anxiety.

Finasteride helps treat skin issues like acne and baldness by blocking testosterone conversion.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

The research found that measuring androgens in urine can give extra information about body metabolism and is linked to androgen levels in the blood, especially in young girls.

Women with PCOS have higher levels of certain androgens, which are good at predicting excess hair growth.

High-intensity interval training (HIIT) is better than moderate-intensity continuous training (MICT) for improving health in overweight women with PCOS.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Acne can be managed with various treatments and requires psychological support due to its emotional impact.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Obesity negatively affects the endometrium, leading to higher miscarriage risk and impaired cell function.